Controlling the diabetes epidemic: How should we screen for undiagnosed diabetes and dysglycaemia?

Diabetic Medicine

Volumn 22, Issue 2, 2005, Pages 207-212

  Simmons, David ^a   Thompson, C F ^b   Engelgau, M M ^c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b MIDDLEMORE HOSPITAL   (New Zealand)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Family history; Glucose; Glycated haemoglobin; Screening; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DYSGLYCEMIA; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; RISK FACTOR; SCREENING;

ADULT; AGED; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 2; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; MIDDLE AGED; PEDIGREE; RISK FACTORS;

EID: 13444283587     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01378.x     Document Type: Article

References (19)

1. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional therapy and risk of complications in patients with Type 2 diabetes mellitus-UKPDS 33. Lancet 1998; 352: 837-353.
2. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes mellitus-UKPDS 38. Br Med J 1998; 317: 703-712.
3. Wareham NJ, Griffin SJ. Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria. Br Med J 2001; 322: 986-988.
4. American Diabetes Association. Clinical Practice Recommendations. American Diabetes Association 1990-1991. Diabetes Care 1991; 14 (Suppl. 2): 7-9.
5. American Diabetes Association. Screening for Diabetes (Position Statement). Diabetes Care 2001; 24 (Suppl. 1): S21-S24.
6. Diabetes Australia Guideline Development Consortium. Draft National Evidence Based Guidelines for the Management of Type 2 Diabetes Mellitus. Sydney: Diabetes Australia Guideline Development Consortium, 2000.
7. Knudson PE, Turner KJ, Sedore A, Weinstock RS. Utility of the American Diabetes Association risk test in a community screening program. Diabetes Care 1998; 21: 1029-1031.
8. Ruige JB, de Neeling JN, Kostense PJ, Bouter LM, Heine RJ. Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care 1997; 20: 491-416.
9. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
10. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristics curves derived from the same cases. Radiology 1983; 148: 839-843.
11. Engelgau MM, Karayan KMV, Herman WH. Screening for Type 2 diabetes. Diabetes Care 2000; 23: 1563-1580.
12. Simmons D, Thompson CF, Volklander D. Polynesians, prone to obesity and Type 2 diabetes but not hyperinsulmaemia. Diabet Med 2001; 18: 193-198.
13. New Zealand Society for the Study of Diabetes. Screening for diabetes in asymptomatic individuals. NZ Med J 1995; 108: 464-465.
14. Simmons D, Powell MJ, Williams DRR. Prevalence of diagnosed and previously undiagnosed diabetes in a predominantly Asian community. Preliminary findings of the Coventry Diabetes Study. Br Med J 1989; 298: 18-21.
15. Alberti KGMM, Zimmet PZ for the WHO consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
16. Metz CE. ROCKIT 9.0B Beta Version. University of Chicago http://www-radiology.uchicago.edu/krl/rocold.htm (accessed 30 December 2003).
17. CDC Cost Effectiveness Study Group. Screening for Type 2 diabetes. JAMA 1998; 280: 1757-1763.
18. Chen THH, Yen MF, Tung TH. A computer simulation model for cost-effectiveness analysis of mass screening for Type 2 diabetes. Diabetes Res Clin Pract 2001; 54 (Suppl. 1): S37-S42.
19. Lawrence JM, Bennett P, Young A, Robinson AM. Screening for diabetes in general practice: cross sectional population study. Br Med J 2001; 323: 548-551.